ArticleExperimental hematology & oncology2018

Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data.

Dilan Paranagama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.